• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺移植后糖尿病肾病病变的逆转

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

作者信息

Fioretto P, Steffes M W, Sutherland D E, Goetz F C, Mauer M

机构信息

Department of Internal Medicine and the Center for the Study of Aging of the National Research Council, University of Padua Medical School, Italy.

出版信息

N Engl J Med. 1998 Jul 9;339(2):69-75. doi: 10.1056/NEJM199807093390202.

DOI:10.1056/NEJM199807093390202
PMID:9654536
Abstract

BACKGROUND

In patients with type I diabetes mellitus who do not have uremia and have not received a kidney transplant, pancreas transplantation does not ameliorate established lesions of diabetic nephropathy within five years after transplantation, but the effects of longer periods of normoglycemia are unknown.

METHODS

We studied kidney function and performed renal biopsies before pancreas transplantation and 5 and 10 years thereafter in eight patients with type I diabetes but without uremia who had mild to advanced lesions of diabetic nephropathy at the time of transplantation. The biopsy samples were analyzed morphometrically.

RESULTS

All patients had persistently normal glycosylated hemoglobin values after transplantation. The median urinary albumin excretion rate was 103 mg per day before transplantation, 30 mg per day 5 years after transplantation, and 20 mg per day 10 years after transplantation (P=0.07 for the comparison of values at base line and at 5 years; P=0.11 for the comparison between base line and 10 years). The mean (+/-SD) creatinine clearance rate declined from 108+/-20 ml per minute per 1.73 m2 of body-surface area at base line to 74+/-16 ml per minute per 1.73 m2 at 5 years (P<0.001) and 74+/-14 ml per minute per 1.73 m2 at 10 years (P<0.001). The thickness of the glomerular and tubular basement membranes was similar at 5 years (570+/-64 and 928+/-173 nm, respectively) and at base line (594+/-81 and 911+/-133 nm, respectively) but had decreased by 10 years (to 404+/-38 and 690+/-111 nm, respectively; P<0.001 and P=0.004 for the comparisons with the base-line values). The mesangial fractional volume (the proportion of the glomerulus occupied by the mesangium) increased from base line (0.33+/-0.07) to 5 years (0.39+/-0.10, P=0.02) but had decreased at 10 years (0.27+/-0.02, P=0.05 for the comparison with the baseline value and P=0.006 for the comparison with the value at 5 years), mostly because of a reduction in mesangial matrix.

CONCLUSIONS

Pancreas transplantation can reverse the lesions of diabetic nephropathy, but reversal requires more than five years of normoglycemia.

摘要

背景

在未患尿毒症且未接受肾移植的I型糖尿病患者中,胰腺移植在移植后五年内并不能改善已有的糖尿病肾病病变,但长期血糖正常的影响尚不清楚。

方法

我们对8例I型糖尿病但无尿毒症且在移植时患有轻度至重度糖尿病肾病病变的患者进行了研究,在胰腺移植前、移植后5年和10年分别评估肾功能并进行肾活检。对活检样本进行形态计量分析。

结果

所有患者移植后糖化血红蛋白值持续正常。移植前尿白蛋白排泄率中位数为每日103mg,移植后5年为每日30mg,移植后10年为每日20mg(基线值与5年值比较,P = 0.07;基线值与10年值比较,P = 0.11)。平均(±标准差)肌酐清除率从基线时的每1.73m²体表面积每分钟108±20ml降至5年时的每1.73m²每分钟74±16ml(P<0.001),10年时为每1.73m²每分钟74±14ml(P<0.001)。肾小球和肾小管基底膜厚度在5年时(分别为570±64和928±173nm)与基线时(分别为594±81和911±133nm)相似,但到10年时有所下降(分别降至404±38和690±111nm;与基线值比较,P<0.001和P = 0.004)。系膜分数体积(系膜占据肾小球的比例)从基线时的0.33±0.07增加到5年时的0.39±0.10(P = 0.02),但在10年时有所下降(0.27±0.02,与基线值比较,P = 0.05;与5年值比较,P = 0.006),主要是由于系膜基质减少。

结论

胰腺移植可逆转糖尿病肾病病变,但逆转需要超过五年的血糖正常。

相似文献

1
Reversal of lesions of diabetic nephropathy after pancreas transplantation.胰腺移植后糖尿病肾病病变的逆转
N Engl J Med. 1998 Jul 9;339(2):69-75. doi: 10.1056/NEJM199807093390202.
2
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.胰腺移植对伴有自身肾脏的胰岛素依赖型糖尿病患者肾小球结构的影响。
Lancet. 1993 Nov 13;342(8881):1193-6. doi: 10.1016/0140-6736(93)92183-t.
3
Pancreas transplantation and reversal of diabetic nephropathy lesions.胰腺移植和糖尿病肾病病变的逆转。
Med Clin North Am. 2013 Jan;97(1):109-14. doi: 10.1016/j.mcna.2012.10.009. Epub 2012 Dec 7.
4
Reversal of diabetic nephropathy: lessons from pancreas transplantation.糖尿病肾病的逆转:胰腺移植的经验教训。
J Nephrol. 2012 Jan-Feb;25(1):13-8. doi: 10.5301/jn.5000061.
5
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes.胰腺移植对胰岛素依赖型糖尿病患者同种异体肾移植肾小球结构的影响。
N Engl J Med. 1989 Jul 13;321(2):80-5. doi: 10.1056/NEJM198907133210204.
6
Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria.早期肾小球病变存在于患有微量白蛋白尿的年轻1型(胰岛素依赖型)糖尿病患者中。
Diabetologia. 1993 Jun;36(6):523-9. doi: 10.1007/BF02743268.
7
Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients.胰腺移植受者肾间质和肾小管病变的重塑
Kidney Int. 2006 Mar;69(5):907-12. doi: 10.1038/sj.ki.5000153.
8
Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect.肾移植中糖尿病肾病的演变。有证据表明同时移植的胰腺具有保护作用。
Transplantation. 1995 Jan 15;59(1):51-7. doi: 10.1097/00007890-199501150-00010.
9
Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.糖化血红蛋白阈值可改善伴有典型糖尿病肾小球病变的2型糖尿病患者肾功能进程的证据。
J Nephrol. 2001 Nov-Dec;14(6):461-71.
10
Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients.单肾不会加速1型糖尿病患者糖尿病肾病病变的发展速度。
Diabetes. 2008 Jun;57(6):1707-11. doi: 10.2337/db07-1610. Epub 2008 Mar 28.

引用本文的文献

1
ECM formation and degradation during fibrosis, repair, and regeneration.纤维化、修复和再生过程中的细胞外基质形成与降解。
NPJ Metab Health Dis. 2025 Jun 10;3(1):25. doi: 10.1038/s44324-025-00063-4.
2
Advances in Cell Replacement Therapies for Diabetes.糖尿病细胞替代疗法的进展
Diabetes. 2025 Apr 24. doi: 10.2337/db25-0037.
3
Nomenclature of renal involvement in diabetes mellitus: unify to manage diversity.糖尿病肾脏病变的命名:统一以应对多样性。
Front Med (Lausanne). 2025 Mar 11;12:1533011. doi: 10.3389/fmed.2025.1533011. eCollection 2025.
4
Fibrosis: cross-organ biology and pathways to development of innovative drugs.纤维化:跨器官生物学与创新药物研发途径
Nat Rev Drug Discov. 2025 Mar 18. doi: 10.1038/s41573-025-01158-9.
5
Induced Genetic Deletion of Cell Division Autoantigen 1 in Adulthood Attenuates Diabetes-Associated Renal Fibrosis.成年期诱导性细胞分裂自身抗原1基因缺失可减轻糖尿病相关的肾纤维化。
Int J Mol Sci. 2025 Feb 26;26(5):2022. doi: 10.3390/ijms26052022.
6
A mathematical model of glomerular fibrosis in diabetic kidney disease to predict therapeutic efficacy.一种用于预测糖尿病肾病中肾小球纤维化治疗效果的数学模型。
Front Pharmacol. 2024 Oct 25;15:1481768. doi: 10.3389/fphar.2024.1481768. eCollection 2024.
7
Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report.抗 C5 单克隆抗体治疗导致补体介导的非典型溶血尿毒综合征的病理缓解:一例报告。
BMC Nephrol. 2024 Jul 15;25(1):224. doi: 10.1186/s12882-024-03662-3.
8
PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis.在增殖性肾小球肾炎和狼疮性肾炎模型中抑制磷脂酰肌醇-3激酶催化亚基α(PIK3CA)
J Clin Invest. 2024 Jun 6;134(15):e176402. doi: 10.1172/JCI176402.
9
Gender effect of glucose, insulin/glucagon ratio, lipids, and nitrogen-metabolites on serum HGF and EGF levels in patients with diabetes type 2.2型糖尿病患者中葡萄糖、胰岛素/胰高血糖素比值、脂质及氮代谢产物对血清肝细胞生长因子和表皮生长因子水平的性别影响
Front Mol Biosci. 2024 Apr 9;11:1362305. doi: 10.3389/fmolb.2024.1362305. eCollection 2024.
10
Combination therapy for kidney disease in people with diabetes mellitus.糖尿病患者肾病的联合治疗。
Nat Rev Nephrol. 2024 Jul;20(7):433-446. doi: 10.1038/s41581-024-00827-z. Epub 2024 Apr 3.